Taro Pharma reports improved Q3 financials, aids Sun Pharma’s growth
Taro Pharma, a subsidiary of Sun Pharma, reported a net profit of $8.5 million for the July-September quarter, marking a significant improvement compared to a net loss of $2.8 million in the same period last year.